Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophagocytic Lymphohistiocytoses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07497438
What this trial is testing

Comparison of Two Etoposide Initiation Strategies for Severe Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Assistance Publique - Hôpitaux de Paris 176
Not applicableLooking for participantsNCT05936086
What this trial is testing

Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH

Who this might be right for
Hemophagocytic Syndrome
shifeng Lou 160
Not applicableStudy completedNCT04902807
What this trial is testing

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

Who this might be right for
Autoimmune Lymphoproliferative SyndromeAutoimmune CytopeniaAutoimmune Diseases+17 more
Institut National de la Santé Et de la Recherche Médicale, France 325
Not applicableUnknownNCT06491719
What this trial is testing

A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT

Who this might be right for
CAEBV (Chronic Active Epstein-Barr Virus Infection) SyndromeEBVHemophagocytic Lymphohistiocytoses
Beijing Friendship Hospital 15
Not applicableUnknownNCT04944511
What this trial is testing

PD-1 Antibody Improve Mixed Chimerism

Who this might be right for
PD-1 AntibodyMixed Chimerism
Beijing Friendship Hospital 20
Large-scale testing (Phase 3)UnknownNCT02862054
What this trial is testing

Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital 30
Not applicableLooking for participantsNCT07800234
What this trial is testing

Establishing a National Egyptian HLH Registry (NEHR)

Who this might be right for
HLHHemophagocytic Lymphohistiocytoses
Ain Shams University 100
Not applicableLooking for participantsNCT05882175
What this trial is testing

Prospective Validation of the OHI Index

Who this might be right for
HLHHemophagocytic LymphohistiocytosesHemophagocytic Syndrome+2 more
Meir Medical Center 300
Large-scale testing (Phase 3)UnknownNCT06038422
What this trial is testing

GTP Regimen in the Treatment of Refractory/Recurrent HLH

Who this might be right for
RefractoryRecurrenceHemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital 15
Not applicableStudy completedNCT02854943
What this trial is testing

Investigation of Ferritin in Critically Ill Patients With Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis (HLH)Macrophage Activation Syndrome (MAS)Hemophagocytic Syndromes
Gunnar Lachmann 2,623
Early research (Phase 1)Study completedNCT01917708
What this trial is testing

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Who this might be right for
Hurler SyndromeFanconi AnemiaGlanzmann Thrombasthenia+12 more
Emory University 10
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Testing effectiveness (Phase 2)Looking for participantsNCT05762640
What this trial is testing

Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)

Who this might be right for
Haemophagocytic Lymphohistiocytosis
Assistance Publique - Hôpitaux de Paris 20
Not applicableStudy completedNCT06391814
What this trial is testing

Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)

Who this might be right for
EBV Associated Lymphoma
Ciusss de L'Est de l'Île de Montréal 1
Testing effectiveness (Phase 2)UnknownNCT05008666
What this trial is testing

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

Who this might be right for
Safety and Efficacy
Sun Yat-sen University 37
Large-scale testing (Phase 3)UnknownNCT03533790
What this trial is testing

DEP-Ru Regimen as a Salvage Therapy for HLH

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital 80
Large-scale testing (Phase 3)UnknownNCT04120090
What this trial is testing

Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
Beijing Friendship Hospital 80
Testing effectiveness (Phase 2)Study completedNCT07034209
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS))

Who this might be right for
Hemophagocytic Lymphohistiocytoses
TJ Biopharma Co., Ltd. 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04551131
What this trial is testing

Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis
St. Jude Children's Research Hospital 10
Post-approval studies (Phase 4)UnknownNCT04999878
What this trial is testing

A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in Induction Therapy of T/NK Cell Lymphoma-associated Hemophagocytic Syndrome.

Who this might be right for
Hemophagocytic SyndromeT/NK-Cell Lymphoma
Zhengzhou University 30
Next Page